Keito Okazaki

Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2

Hiroki Shima, K. Igarashi, H. Motohashi, 2017, The Journal of Biological Chemistry.

The Mediator Subunit MED16 Transduces NRF2-Activating Signals into Antioxidant Gene Expression

Y. Katoh, Masayuki Yamamoto, Hiroki Shima, 2015, Molecular and Cellular Biology.

The Mediator Subunit MED 16 Transduces NRF 2-activating Signals into 1 Antioxidant Gene Expression 2 3

Y. Katoh, Hiroki Shima, K. Igarashi, 2015 .

Metabolic features of cancer cells in NRF2 addiction status

H. Motohashi, T. Papagiannakopoulos, Keito Okazaki, 2020, Biophysical Reviews.

Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers

K. Kinoshita, A. Sakurada, Masayuki Yamamoto, 2020, Nature Communications.

O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1

Masayuki Yamamoto, Hiroki Shima, K. Igarashi, 2018, Molecular and Cellular Biology.

Metabolic features of cancer cells in NRF2 addiction status

H. Motohashi, T. Papagiannakopoulos, Keito Okazaki, 2020, Biophysical Reviews.

CEBPB is Required for NRF2-Mediated Drug Resistance in NRF2-Activated Non-Small Cell Lung Cancer Cells.

K. Kinoshita, F. Katsuoka, H. Motohashi, 2022, Journal of biochemistry.

NRF2 signaling in cytoprotection and metabolism.

H. Motohashi, Keito Okazaki, Takaaki Akaike, 2023, British journal of pharmacology.

Aging Exacerbates Murine Lung Ischemia-Reperfusion Injury by Excessive Inflammation and Impaired Tissue Repair Response.

H. Motohashi, Tatsuaki Watanabe, K. Hayasaka, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.